person · Reporting owner
Rosebrough Walter M Jr
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 11, 2026 | September 15, 2026 |
| STERIS plcSTE · Entity 3228 | Director · President & CEO | November 09, 2020 | November 10, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectsee footnote | 20,000 |
Last balance in matching sequence
After 2026-09-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2026-09-11 · Purchase · Acquired 7,000 · Balance 17,000 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. Row 3 · 2026-09-14 · Purchase · Acquired 3,000 · Balance 20,000 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. |
| Common StockSEC Table I · non-derivative | Direct | 832 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 832 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
STERIS plc
Report date November 09, 2020 · Filed November 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 58,391 |
Reported balance
After 2020-11-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-09 · Sale · Disposed 3,014 · Balance 58,391 F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,605 |
Reported balance
After 2020-11-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-11-09 · Sale · Disposed 6,786 · Balance 51,605 F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,405 |
Reported balance
After 2020-11-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-11-09 · Sale · Disposed 200 · Balance 51,405 F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit.
F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,947 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 14,947 · Balance 14,947 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 48,895 · Balance 0 F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 13,000 · Balance 0 F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2018-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-28 · Disposition to issuer · Disposed 119,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 111,000 · Balance 0 F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 112,340 · Balance 0 F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 136,000 · Balance 0 F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 136,268 · Balance 0 F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 15, 2026 20:56 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | PurchaseCommon Stock | 3,000 | $54.29 | $162,870.00 |
DisclosureSEC source: 0001413087-26-000007 · primarydocument.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 20,000 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.nature: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:56 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | PurchaseCommon Stock | 7,000 | $54.11 | $378,770.00 |
DisclosureSEC source: 0001413087-26-000007 · primarydocument.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 17,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.nature: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. Read SEC document |
| April 01, 2026 Filed Apr 6, 2026 21:15 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 3,779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000005 · primarydocument.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,779 Underlying: Common Stock · 3,779 shares Expires not disclosed F1 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2026 Filed Apr 21, 2026 21:45 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 832 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000006 · primarydocument.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 832 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2026 Filed Apr 21, 2026 21:45 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 832 | $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000006 · primarydocument.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 21:08 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 14,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000027 · wk-form4_1771016879.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,947 Underlying: Common Stock · 14,947 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:14 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 10,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:14 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 10,339 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| January 03, 2026 Filed Apr 21, 2026 21:45 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 832 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000006 · primarydocument.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 832 Underlying: Common Stock · 832 shares Expires not disclosed F2 · date: This Form 4 was filed after the due date due to an inadvertent administrative oversight. F3 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000028 · wk-form4_1739577865.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units were issued on February 10, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. F3 · derivative.expiration_date: These Deferred Stock Units were issued on February 10, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 14,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000028 · wk-form4_1739577865.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,695 Underlying: Common Stock · 14,695 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2025 Filed Feb 15, 2025 00:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000028 · wk-form4_1739577865.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:03 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:03 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 11,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,689 Underlying: Common Shares · 11,689 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000029 · wf-form4_167632720601718.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 13, 2021. There was an inadvertently discrepancy in the originally filed Form 4 that showed the distribution date as February 15, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 13, 2023. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 13, 2021. There was an inadvertently discrepancy in the originally filed Form 4 that showed the distribution date as February 15, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 13, 2023. Read SEC document |
| February 13, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000029 · wf-form4_167632720601718.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:27 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 10,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000029 · wf-form4_167632720601718.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,339 Underlying: Common Stock · 10,339 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:47 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F4 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:47 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: 14,000 of these Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 21:47 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F3 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 3,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000023 · wf-form4_161352381606550.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. F4 · derivative.expiration_date: These Deferred Stock Units vested on February 15, 2019. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 15, 2021. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000023 · wf-form4_161352381606550.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,881 Underlying: Common Stock · 6,881 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F3 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2024 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:04 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 3,603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-21-000023 · wf-form4_161352381606550.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · ownership.direct: 14,000 of these Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 200 | $195.01 | $39,002.00 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,405 F3 · balance_after: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F4 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,786 | $194.25 | $1,318,180.50 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,605 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,014 | $193.02 | $581,762.28 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,391 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,300 | $182.19 | $236,847.00 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,405 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $182.03 to $182.49 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4 · balance_after: These 61,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F5 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,363 | $181.52 | $1,155,011.76 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,705 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $181.02 to $182.00 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,337 | $180.60 | $422,062.20 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,068 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $179.98 to $180.97 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:35 UTC | STERIS plc STE · Entity 3228 | GiftOrdinary Shares | 4,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,405 Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 17 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Ordinary Shares · 51,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: This option is part of an option to purchase 136,000 STERIS ordinary shares, of which 102,000 are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 136,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 709 | $156.79 | $111,164.11 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 14 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.4850 to $157.0300 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F12 · balance_after: These 76,302 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F13 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 5,874 | $155.79 | $915,110.46 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 13 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,011 F10 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.4300 to $156.3950 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 9,799 | $155.03 | $1,519,138.97 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 12 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,885 F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.4250 to $155.4200 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 11,552 | $154.05 | $1,779,585.60 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 11 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,684 F8 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.4200 to $154.4200 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 23,066 | $152.91 | $3,527,022.06 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 10 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,236 F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $152.3900 to $153.3800 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 51,000 | $77.07 | $3,930,570.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 9 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 16 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Ordinary Shares · 51,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: This option is part of an option to purchase 136,000 STERIS ordinary shares, of which 102,000 are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 136,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 28,085 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 15 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,085 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: This option is part of an option to purchase 112,340 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 112,349 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,996 | $156.87 | $313,112.52 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 8 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.6550 to $157.1950 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 13,137 | $155.88 | $2,047,795.56 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,298 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.6500 to $156.6400 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 35,867 | $155.29 | $5,569,786.43 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,435 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.6450 to $155.6450 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 51,000 | $77.07 | $3,930,570.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,539 | $157.27 | $1,028,388.53 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.9000 to $157.6500 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,415 | $156.38 | $534,037.70 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,841 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.8050 to $156.7750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 10,131 | $155.24 | $1,572,736.44 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,256 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.7950 to $155.7550 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 28,085 | $69.72 | $1,958,086.20 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 99,464 | Not disclosed Strike: $182.22 | Not disclosed |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,464 Underlying: Ordinary Shares · 99,464 shares Expires 2030-06-01 F8 · price: This option becomes exercisable as follows: 24,866 on June 1, 2021; 24,866 on June 1, 2022; 24,866 on June 1, 2023 and 24,866 on June 3, 2024. F8 · derivative.exercise_date: This option becomes exercisable as follows: 24,866 on June 1, 2021; 24,866 on June 1, 2022; 24,866 on June 1, 2023 and 24,866 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 2,150 | $165.65 | $356,147.50 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,302 F6 · shares: 2,150 shares were withheld from the 4,681 restricted shares that vested on June 1, 2020. These 2,150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 ordinary shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F7 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023 and 2,217 on June 3, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.